Lv41
538 积分 2023-11-19 加入
Engineered lactococcus lactis intrapleural therapy promotes regression of malignant pleural effusion by enhancing antitumor immunity
4小时前
待确认
PITX1 facilitates the proliferation and tumorigenesis of NSCLC cells via potentiating PHB2-mediated AKT activity
27天前
已完结
Development of ICT01, a first-in-class, anti-BTN3A antibody for activating Vγ9Vδ2 T cell–mediated antitumor immune response
5个月前
已完结
Talicabtagene autoleucel for relapsed or refractory B-cell malignancies: results from an open-label, multicentre, phase 1/2 study
5个月前
已完结
Breaking barriers: the emerging promise of CAR-T cell therapy in solid tumors
6个月前
已完结
Who wins the combat, CAR or TCR?
6个月前
已完结
肺孢子菌肺炎的临床研究进展
9个月前
已完结
Assessment of Riociguat-related adverse events: a disproportionality analysis utilizing the FDA adverse event reporting system database
10个月前
已完结
Assessment of Riociguat-related adverse events: a disproportionality analysis utilizing the FDA adverse event reporting system database
10个月前
已完结
皖公网安备34019202002308
